Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson reiterates a Buy rating on Hologic (NASDAQ:HOLX) and maintains a $90 price target.
May 03, 2024 | 9:39 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham analyst Mike Matson reaffirms a Buy rating on Hologic, with a price target of $90.
The reiteration of a Buy rating and maintenance of a $90 price target by a reputable analyst could positively influence investor sentiment towards Hologic, potentially driving up its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100